---
title: "SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 43.35 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265915242.md"
datetime: "2025-11-14T11:52:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265915242.md)
  - [en](https://longbridge.com/en/news/265915242.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265915242.md)
generator: "portal-rs"
---

# SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 43.35 M

Revenue: As of FY2025 Q3, the actual value is USD 43.35 M.

EPS: As of FY2025 Q3, the actual value is USD 0.12.

EBIT: As of FY2025 Q3, the actual value is USD 15.81 M.

### Segment Revenue

-   Total revenues for the third quarter of 2025 were $43 million, representing an 18% year-over-year decrease.
-   Franchising revenue was $10 million, a decrease of 37% YoY.
-   Procurement revenue was $13 million, a decrease of 24% YoY.
-   Management services revenue was $9 million, a decrease of 22% YoY.
-   Rental services revenue was $6 million, an increase of 51% YoY.

### Operational Metrics

-   Income from operations for the third quarter was $16 million, a 15% increase year-over-year.
-   Net income attributable to SBC Medical Group for the third quarter was $13 million, a 353% increase year-over-year.
-   EBITDA for the third quarter was $17 million, a 12% increase year-over-year, with an EBITDA margin of 38%.
-   Gross profit was $31 million, a decrease of 29% YoY.
-   Operating expenses were $15 million, a decrease of 50% YoY.

### Cash Flow

-   Net cash used in operating activities for the nine months ended September 30, 2025, was - $27,295,426.
-   Net cash provided by investing activities was $3,239,523.
-   Net cash provided by financing activities was $18,470,001.

### Unique Metrics

-   The number of franchise locations increased by 34 to 258 as of September 30, 2025.
-   The number of customers in the last twelve months was 6.5 million, a 14% increase year-over-year.
-   The repeat rate for customers visiting franchisee clinics twice or more was 72%.

### Outlook / Guidance

SBC Medical plans to focus on delivering high-quality solutions, advancing multi-brand initiatives in the dermatology segment, and building a stronger business foundation in overseas markets to pursue sustainable growth toward 2026. The company anticipates continued growth in its network of locations and customer base, aiming for further expansion both domestically and overseas.

### Related Stocks

- [SBCWW.US](https://longbridge.com/en/quote/SBCWW.US.md)

## Related News & Research

- [Intuit Stock Falls Ahead of Q4 Earnings: What Investors Need to Know](https://longbridge.com/en/news/296933970.md)
- [Anthropic expected to tell investors it sees over $30 trillion in potential revenue, WSJ reports](https://longbridge.com/en/news/296941513.md)
- [Nvidia Earnings: Wall Street Expects Growth to Slow in Q2 — Dan Niles Says Hyperscalers Are Spending Like Never Before](https://longbridge.com/en/news/296822352.md)
- [Wearable Devices Files First-Half 2026 Results and Corporate Update](https://longbridge.com/en/news/296836359.md)
- [Z3 Capital Partners LLC Buys 1,160 Shares of Meta Platforms, Inc. $META](https://longbridge.com/en/news/296881717.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**